MetaADEDB 2.0 @ LMMD
perampanel
(PRMWGUBFXWROHD-UHFFFAOYSA-N)
Structure
SMILES
N#Cc1ccccc1c1cc(cn(c1=O)c1ccccc1)c1ccccn1
Type(s)
Approved
ATC code(s)
N03AX22
Molecular Formula:
C23H15N3O
Molecular Weight:
349.385
Log P:
4.4382
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
58.68
CAS Number(s):
380917-97-5
Synonym(s)
1.
perampanel
2.
3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one
External Link(s)
MeSHC551441
PubChem Compound9924495
BindingDB50184410
ChEBI71013
CHEMBLCHEMBL1214124
DrugBankDB08883
DrugCentral4684
IUPHAR/BPS Guide to PHARMACOLOGY7050
KEGGdr:D08964
Therapeutic Target DatabaseD0U3ED
ZINC30691797
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 28SIDER
US FAERS
2SomnolenceFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3AgitationFAERS: 13US FAERS
4Drug ineffectiveFAERS: 13US FAERS
5Suicide attemptFAERS: 12US FAERS
6AngerFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7FatigueFAERS: 8SIDER
US FAERS
8AtaxiaFAERS: 7SIDER
US FAERS
9HeadacheFAERS: 7SIDER
US FAERS
10OverdoseFAERS: 6US FAERS
11Physical assaultFAERS: 6US FAERS
12Mood swingsFAERS: 5SIDER
US FAERS
13ParanoiaFAERS: 5US FAERS
14Product use issueFAERS: 5US FAERS
15AnxietyFAERS: 4SIDER
US FAERS
16DysarthriaFAERS: 4SIDER
US FAERS
17VertigoFAERS: 4SIDER
US FAERS
18ConstipationFAERS: 3SIDER
US FAERS
19DisorientationFAERS: 3US FAERS
20Drug administered to patient of inappropriate ageFAERS: 3US FAERS
21EpilepsyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
22FractureFAERS: 3US FAERS
23Gait inabilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
24NauseaFAERS: 3SIDER
US FAERS
25Personality ChangeFAERS: 3US FAERS
26Psychiatric symptomFAERS: 3US FAERS
27Status EpilepticusFAERS: 3US FAERS
28VomitingFAERS: 3SIDER
US FAERS
29Accidental overdoseFAERS: 2US FAERS
30Acute kidney injuryFAERS: 2US FAERS
31AphasiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Back PainFAERS: 2SIDER
US FAERS
33Completed SuicideFAERS: 2US FAERS
34Drug withdrawal convulsionsFAERS: 2US FAERS
35ErythemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Feeling abnormalFAERS: 2SIDER
US FAERS
37Memory impairmentFAERS: 2SIDER
US FAERS
38Musculoskeletal PainFAERS: 2SIDER
US FAERS
39MyalgiaFAERS: 2SIDER
US FAERS
40Myocardial InfarctionFAERS: 2US FAERS
41PneumoniaFAERS: 2US FAERS
42Prescription drug used without a prescriptionFAERS: 2US FAERS
43RestlessnessFAERS: 2US FAERS
44RhabdomyolysisFAERS: 2US FAERS
45Skin UlcerFAERS: 2US FAERS
46SomnambulismFAERS: 2US FAERS
47Therapy changeFAERS: 2US FAERS
48TremorFAERS: 2US FAERS
49Violence-related symptomFAERS: 2US FAERS
50Vulvovaginal discomfortFAERS: 2US FAERS
51Abdominal PainFAERS: 1US FAERS
52Accidental exposure to product by childFAERS: 1US FAERS
53AcneFAERS: 1US FAERS
54Acute psychosisFAERS: 1US FAERS
55Ankle FractureFAERS: 1US FAERS
56ArthralgiaFAERS: 1SIDER
US FAERS
57AsphyxiaFAERS: 1US FAERS
58AstheniaFAERS: 1SIDER
US FAERS
59Autoimmune hepatitisFAERS: 1US FAERS
60BlindnessFAERS: 1US FAERS
61Blood glucose increasedFAERS: 1US FAERS
62Blood sodium decreasedFAERS: 1US FAERS
63BradykinesiaFAERS: 1US FAERS
64BradyphreniaFAERS: 1US FAERS
65Congenital diaphragmatic herniaFAERS: 1US FAERS
66CryingFAERS: 1US FAERS
67CyanosisFAERS: 1US FAERS
68Cystic FibrosisFAERS: 1US FAERS
69DeafnessFAERS: 1US FAERS
70DeliriumFAERS: 1US FAERS
71Delusional perceptionFAERS: 1US FAERS
72DrowningFAERS: 1US FAERS
73Drug DependenceFAERS: 1US FAERS
74Drug administration errorFAERS: 1US FAERS
75Drug ineffective for unapproved indicationFAERS: 1US FAERS
76Electroencephalogram abnormalFAERS: 1US FAERS
77EncephalitisFAERS: 1US FAERS
78Erection increasedFAERS: 1US FAERS
79Euphoric moodFAERS: 1SIDER
US FAERS
80Foaming at mouthFAERS: 1US FAERS
81Head BangingFAERS: 1US FAERS
82HostilityFAERS: 1US FAERS
83HyperkinesiaFAERS: 1US FAERS
84InfluenzaFAERS: 1US FAERS
85Intentional self-injuryFAERS: 1US FAERS
86LeukocytosisFAERS: 1US FAERS
87Lip swellingFAERS: 1US FAERS
88MalaiseFAERS: 1US FAERS
89MetamorphopsiaFAERS: 1US FAERS
90Muscle SpasticityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
91NervousnessFAERS: 1US FAERS
92Ophthalmoplegic MigraineFAERS: 1US FAERS
93Peripheral swellingFAERS: 1US FAERS
94PolydipsiaFAERS: 1US FAERS
95Postictal psychosisFAERS: 1US FAERS
96PruritusFAERS: 1US FAERS
97Psychotic symptomFAERS: 1US FAERS
98Respiratory DepressionFAERS: 1US FAERS
99RetchingFAERS: 1US FAERS
100Secretion dischargeFAERS: 1US FAERS
101StaringFAERS: 1US FAERS
102Sudden deathFAERS: 1US FAERS
103SwellingFAERS: 1US FAERS
104Therapy cessationFAERS: 1US FAERS
105ThrombocytopeniaFAERS: 1US FAERS
106Tongue movement disturbanceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Transaminases increasedFAERS: 1US FAERS
108Urinary RetentionFAERS: 1US FAERS
109Visual ImpairmentFAERS: 1US FAERS
110White blood cell count decreasedFAERS: 1US FAERS
111Cortical DysplasiaCanada Vigilance: 1Canada Vigilance
112DiplopiaSIDER
113Ear and labyrinth disordersSIDER
114HypersomniaSIDER
115InfectionSIDER
116InfestationSIDER
117LacerationSIDER
118Limb injurySIDER
119MalnutritionSIDER
120Musculoskeletal discomfortSIDER
121Oropharyngeal painSIDER
122Skin lacerationSIDER
123nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.